Search results for: Recombinant Bovine Aprotinin Proteins
#33298149 2020/12/09 To Up
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.The peak of the global COVID-19 pandemic has not yet been reached, and many countries face the prospect of a second wave of infections before effective vaccinations will be available. After an initial phase of viral replication, some patients develop a second illness phase in which the host thrombotic and inflammatory responses seem to drive complications. Severe COVID-19 disease is linked to high mortality, hyperinflammation, and a remarkably high incidence of thrombotic events. We hypothesize a crucial pathophysiological role for the contact pathway of coagulation and the kallikrein-bradykinin pathway. Therefore, drugs that modulate this excessive thromboinflammatory response should be investigated in severe COVID-19.
T Vanassche, M M Engelen, Q Van Thillo, J Wauters, J Gunst, C Wouters, C Vandenbriele, S Rex, L Liesenborghs, A Wilmer, P Meersseman, G Van den Berghe, D Dauwe, G Verbeke, M Thomeer, T Fivez, D Mesotten, D Ruttens, L Heytens, I Dapper, S Tuyls, B De Tavernier, P Verhamme,
1450 related Products with: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.0.1ml
#31840729 // To Up
A nanometer-sized protease inhibitor for precise cancer diagnosis and treatment.Inhibition of pro-cancer proteases is a potent anticancer strategy. However, protease inhibitors are mostly developed in the forms of small molecules or peptides, which normally suffer from insufficient metabolic stability. The fast clearance significantly impairs the antitumor effects of these inhibitors. In this study, we report a nanometer-sized inhibitor of a pro-cancer protease, suppressor of tumorigenicity 14 (st14), which has been reported as a potent prognostic marker for multiple cancers. This st14 inhibitor was fabricated by conjugating a recombinant st14 inhibitor (KD1) with carbon quantum dots (CQDs). CQD-KD1 not only demonstrated high potency of inhibiting st14 activity in biochemical experiments, but also remarkably suppressed the invasion of breast cancer cells. In contrast to the original recombinant KD1, CQD-KD1 demonstrated a prolonged retention time in plasma and at the tumor site because of the reduced renal clearance. Consistently, CQD-KD1 demonstrated enhanced efficacies of suppressing tumor growth and cancer metastases in vivo. In addition, CQD-KD1 precisely imaged tumor tissues in cancer-grafted mice by specifically targeting the over-expressed st14 on the tumor cell surface, which indicates CQD-KD1 as a potent probe for the fluorescence guided surgery of tumor resection. In conclusion, this study demonstrates that CQD-KD1 is a highly potent diagnostic and therapeutic agent for cancer treatments.
Ping Hu, Le Shang, Jincan Chen, Xuzheng Chen, Chun Chen, Wanjin Hong, Mingdong Huang, Peng Xu, Zhuo Chen
1307 related Products with: A nanometer-sized protease inhibitor for precise cancer diagnosis and treatment.0.1ml (1mg/ml)50ul (1mg/ml) 100ul100μg0.1ml (1mg/ml)96tests100μg
#31421726 2019/06/20 To Up
Sorbitol/methanol mixed induction reduces process impurities and improves centrifugal dewatering in Pichia pastoris culture.This study investigates how sorbitol/methanol mixed induction affects fermentation performance, dewatering characteristics of cells during harvesting and the profile of host cell proteins (HCP) in the process fluid when producing the target recombinant protein aprotinin. Compared to standard methanol induction, sorbitol/methanol (1:1, C-mol/C-mol) mixed induction improved cellular viability from 92.8â¯Â±â¯0.3% to 97.7â¯Â±â¯0.1% although resulted in a reduced product yield from 1.65â¯Â±â¯0.03â¯gâ¯L to 1.12â¯Â±â¯0.07â¯gâ¯L. On the other hand, average oxygen consumption rate (OUR) dropped from 241.4â¯Â±â¯21.3â¯mmolâ¯Lâ¯h to 145.5â¯Â±â¯6.7â¯mmolâ¯Lâ¯h. Cell diameter decreased over time in the mixed induction, resulting in a D value of 3.14â¯Î¼m at harvest compared to 3.85â¯Î¼m with methanol. The reduction in cell size enhanced the maximum dewatering efficiency from 78.1â¯Â±â¯3.9% to 84.5â¯Â±â¯3.3% as evaluated by using an established ultra scale-down methodology that models pilot and industrial scale disc stack centrifugation. Seventy host cell proteins (HCPs) were identified in clarified supernatant when using sorbitol/methanol mixed induction regimen. The total number of HCPs identified with standard methanol induction was nearly one hundred. The downstream process advantage of the mixed induction lies in improved product purity by reducing both cell mortality and level of released whole cell proteins. This needs to be balanced and optimised against the observed reduction in product yield during fermentation.
Baolong Wang, Darren Nesbeth, Eli Keshavarz-Moore
1057 related Products with: Sorbitol/methanol mixed induction reduces process impurities and improves centrifugal dewatering in Pichia pastoris culture.case1 mgcase1 mL100 µg1 L.4/120 Packing /sleeve/bo 25 G 100 G96 tests4/120 Packing /sleeve/bo
#30446013 2018/11/16 To Up
Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively eliminates tumor cells. However, the short biological half-life of this molecule limits its potential use in the clinic. Our aim was to construct a recombinant strain of nonpathogenic Lactococcus lactis bacteria as a vector for effective and prolonged human TRAIL production. Herein, we examined the expression and secretion conditions leading to the production of biologically active protein in vitro.
Katarzyna CiaÄma, Jerzy WiÄckiewicz, Sylwia KÄdracka-Krok, Magdalena Kurtyka, MaÅgorzata Stec, Maciej Siedlar, Jarek Baran
1356 related Products with: Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions.1 mg96T96T100 ug100 ug10 100 ug100ul1mg1 mg5 1 kit(96 Wells)
#30238848 2018/09/25 To Up
Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells.In a tumor microenvironment, endothelial cell migration and angiogenesis allow cancer to spread to other organs causing metastasis.Â Indeed, a number of molecules that are involved in cytoskeleton re-organization and intracellular signaling have been investigated for their effects on tumor cell growth and metastasis. Alongside that, Amblyomin-X, a recombinant Kunitz-type protein, has been shown to reduce metastasis and tumor growth in in vivo experiments. In the present report, we provide a mechanistic insight to these antitumor effects, this is,Â Amblyomin-X modulates Rho-GTPases and uPAR signaling, and reduces the release of MMPs, leading to disruption of the actin cytoskeleton and decreased cell migration of tumor cell lines. Altogether, our data support a role for Amblyomin-X as a novel potential antitumor drug.
Mariana Costa Braga Schmidt, Katia L P Morais, MaÃra Estanislau Soares de Almeida, Asif Iqbal, Mauricio Barbugiani Goldfeder, Ana Marisa Chudzinski-Tavassi
2588 related Products with: Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells.1001021mg96tests1mg200 1.00 flask100 ug/vial1mg1001 mg
#29525559 2018/03/06 To Up
Personality traits and facets linked with self-reported alcohol consumption and biomarkers of liver health.This study examines whether the association between Five Factor Model personality traits and alcohol consumption extends beyond self-report to biomarkers of alcohol consumption.
Martina Luchetti, Angelina R Sutin, Alessandro Delitala, Yannick Stephan, Edoardo Fiorillo, Michele Marongiu, Marco Masala, David Schlessinger, Antonio Terracciano
2452 related Products with: Personality traits and facets linked with self-reported alcohol consumption and biomarkers of liver health.1000 TESTS/0.65ml200ul10 mg100 mg25 mg100 mg 25 MG10 mg50 ug 100ug200ug
#29334656 2018/01/03 To Up
Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2.Bone remodeling relies on a delicate balance between formation and resorption of bone tissues, processes in which bone-forming osteoblasts and bone-resorbing osteoclasts play central roles. Recently, we reported that anticoagulant activated protein C (APC) promotes osteoblast proliferation, but the role of the blood coagulation system in bone remodeling remains unclear. In this study, to further elucidate the relationship between bone remodeling and blood coagulation, we investigated the effect of APC on osteoclast differentiation.
Kakunoshin Yoshida, Nobuyuki Akita, Takayuki Okamoto, Kunihiro Asanuma, Atsumasa Uchida, Akihiro Sudo, Motomu Shimaoka, Koji Suzuki, Tatsuya Hayashi
2006 related Products with: Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2.100 ug/vial50ug50ug50ug 100ul50ug100ul50ug50ug50ug50ug200ul
#29079148 2017/10/24 To Up
Trypsin of Litopenaeus vannamei is required for the generation of hemocyanin-derived peptides.Hemocyanin is a copper containing respiratory glycoprotein in arthropods and mollusks, which also have multiple functions inÂ vivo. Recent studies have shown that hemocyanin could generate several peptides, which play important roles in shrimp innate immunity. However, how these hemocyanin-derived peptides are generated is still largely unknown. In this study, we report for the first time that the generation of hemocyanin-derived peptides was closely correlated with trypsin expression in shrimp hepatopancreas following infection with different bacteria. RNA interference (RNAi) mediated knockdown of trypsin or treatment with the serine protease inhibitor, aprotinin, resulted in significant decrease in the levels of hemocyanin-derived peptides. Moreover, recombinant trypsin (rTrypsin) was able to hydrolyse hemocynin inÂ vitro with the hydrolysate having a high bacterial agglutination activity while the denatured hemocynin untreated with rTrypsin lost its agglutination activity. Taken together, our current results showed that the generation of hemocyanin-derived peptides correlates with an increase trypsin expression.
Changping Li, Fan Wang, Jude Juventus Aweya, Defu Yao, Zhou Zheng, He Huang, Shengkang Li, Yueling Zhang
1626 related Products with: Trypsin of Litopenaeus vannamei is required for the generation of hemocyanin-derived peptides.100 ml 1 mg 5 G0.1 mg1 g0.1 ml25 µg100 ul0.1 mg0.25 mg25 μg1 mg
#28472911 // To Up
Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology.The objectives of the present investigation were to prepare recombinant human insulin entrapped Eudragit-S100 microspheres containing protease inhibitors and to precisely analyze the outcome of different formulation variables on the microspheres properties using a response surface methodology to develop an optimized formulation with desirable features.
Gauravkuma Agrawal, Pravin Wakte, Santosh Shelke
1897 related Products with: Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology.25 μg100 TESTS1 mg20ug1 mg20 ug96T0.1 mg100 mg500
#28166139 // To Up
Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.Appropriate antithrombotic therapy is critical for successful outcomes in reconstructive microsurgical procedures involving free tissue transfer. The annexin V-6L15 (ANV-6L15) fusion protein was developed as a targeted antithrombotic reagent. Annexin V specifically binds to exposed phosphatidylserine on apoptotic or injured cells, and prevents coagulation and cell adhesion, whereas 6L15 inhibits tissue factor-VIIa pathway within the coagulation cascade. The treatment efficacy of ANV-6L15 on rat island muscle and pedicled abdominal fasciocutaneous flaps following ischemic injury and ischemia-reperfusion injury (IRI) was evaluated.
Victor Bong-Hang Shyu, Chung En Hsu, Chih-Jen Wen, Tze-Chein Wun, Rui Tang, Samuel Achilefu, Fu-Chan Wei, Hui-Yun Cheng
1153 related Products with: Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.100ul1000 TESTS/0.65ml10102.00 ug100ug Lyophilized101mg0.1 mg1000
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia